Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST001246)

Reversed phase UNSPECIFIED ION MODE (Analysis AN002070)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9
FA 20:0; [M-H]-	ME292520	0.68	0.74	0.69	2.19	0.54	0.59	0.65	0.67	0.58
FA (20:5) (eicosapentaenoic acid) [M-H]-	ME292518	0.96	1.26	1.17	1.28	1.00	0.95	0.92	1.20	0.63
FA (14:1) (physeteric acid) [M-H]-	ME292504	0.60	0.41	0.43	1.30	1.74	1.81	1.90	0.45	0.81
FA (20:2) (eicosadienoic acid) [M-H]-	ME292514	0.67	1.56	1.30	1.63	1.24	1.28	1.34	1.20	0.13
FA (18:3) (linolenic acid) [M-H]-	ME292512	0.74	0.81	0.91	2.05	0.67	0.64	0.74	0.73	0.52
FA (20:4) (arachidonic acid) [M-H]-	ME292517	1.16	1.13	1.18	1.39	0.98	1.08	1.12	1.10	0.35
FA (15:0) (pentadecylic acid) [M-H]-	ME292505	1.13	1.38	1.25	0.46	1.12	1.13	1.19	1.25	1.11
FA (18:0) (stearic acid) [M-H]-	ME292509	1.35	1.11	1.05	1.10	0.88	0.92	1.05	0.98	0.64
FA (16:0) (palmitic acid) [M-H]-	ME292506	3.21	0.27	0.44	0.74	0.52	0.35	0.73	0.67	0.36
FA (16:1) (palmitoleic acid) [M-H]-	ME292507	0.90	1.03	0.98	1.08	1.03	1.08	1.16	0.92	0.95
FA (11:0) (undecylic acid) [M-H]-	ME292501	0.98	1.08	1.02	0.99	0.95	1.00	1.06	1.02	0.99
FA (14:0) (myristic acid) [M-H]-	ME292503	2.33	0.40	0.45	1.53	0.50	0.67	0.43	0.42	0.25
FA (12:0) (lauric acid) [M-H]-	ME292502	0.97	0.90	0.92	1.15	1.02	1.00	1.07	0.81	0.94
FA (10:0) (capric acid) [M-H]-	ME292500	1.08	1.19	1.21	0.88	1.04	0.92	1.10	1.22	0.89
FA (17:0) (margaric acid) [M-H]-	ME292508	1.01	1.07	1.21	0.80	1.06	1.14	1.11	1.12	1.01
FA 22:0; [M-H]-	ME292523	0.95	1.21	1.15	0.80	1.14	1.13	1.09	1.17	1.02
FA (18:1) (oleic acid) [M-H]-	ME292510	1.88	0.71	0.71	0.69	0.73	0.69	0.72	0.73	1.08
FA 19:0; [M-H]-	ME292519	0.48	0.65	0.66	2.81	0.48	0.52	0.56	0.65	0.20
FA (20:1) (eicosenoic acid) [M-H]-	ME292513	0.57	0.76	0.80	2.39	0.73	0.65	0.80	0.72	0.31
FA (18:2) (linoleic acid) [M-H]-	ME292511	1.43	0.96	0.88	0.95	0.79	0.79	0.82	0.88	0.95
FA (20:3) (eicosatrienoic acid) A [M-H]-	ME292515	1.20	0.73	0.78	1.54	0.74	0.72	0.68	0.76	0.70
FA (20:3) (homo-gamma-linolenic acid) B [M-H]-	ME292516	0.80	0.67	0.64	2.15	0.61	0.60	0.62	0.59	0.57

Factors:

F1	Genoytpe:KO HADHA \| Treatment:Control
F2	Genoytpe:MUT HADHA \| Treatment:10 Day Fatty Acid Supplementation
F3	Genoytpe:MUT HADHA \| Treatment:11 Day Fatty Acid Supplementation
F4	Genoytpe:MUT HADHA \| Treatment:12 Day Fatty Acid Supplementation
F5	Genoytpe:MUT HADHA \| Treatment:6 Day Fatty Acid Supplementation
F6	Genoytpe:MUT HADHA \| Treatment:7 Day Fatty Acid Supplementation
F7	Genoytpe:MUT HADHA \| Treatment:8 Day Fatty Acid Supplementation
F8	Genoytpe:MUT HADHA \| Treatment:9 Day Fatty Acid Supplementation
F9	Genoytpe:WT HADHA \| Treatment:12 Day Fatty Acid Supplementation

Data matrix